Information for TB-500 TB-500 is a synthetic peptide derivative of thymosin 4 (T4) whose biological activity remains unconfirmed
Standard sleep protocol The most commonly recommended approach for sleep optimization
Consequently, simulations suggest that while doxorubicin redox metabolism impacts GSH metabolism, the concentrations required to illicit a toxic response, with either a single or extended exposure, reside outside that of the therapeutic dosing range
Building on these findings, our recent study demonstrated that sulforaphane prevented ASD-associated phenotypes induced by valproic acid, including oxidative stress, synaptic loss and neural activity disruption, highlighting sulforaphanes potential as a preventative strategy against early life ASD risk (Bessetti et al., 2025)
Up to 15% 15%
TB-500 is prohibited under the 2026 WADA Prohibited List, Section S2